Recombinant adenovirus vector mediated expression of lipoprotein (a) [Lp(a)] in rabbit plasma

被引:3
作者
Ramharack, R
Bocan, TMA
Imperiale, MJ
Spahr, MA
机构
[1] Warner Lambert Co, Parke Davis Pharmaceut Res, Dept Cardiovasc Therapeut, Ann Arbor, MI 48105 USA
[2] Univ Michigan, Sch Med, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA
来源
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS | 1999年 / 1438卷 / 03期
关键词
lipoprotein (a); apolipoprotein (a); coupling; recombinant adenovirus; hepatocyte; rabbit;
D O I
10.1016/S1388-1981(99)00065-7
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Lipoprotein (a) [Lp(a)] is a heterodimer of apolipoprotein (a) [apo(a)] and apolipoprotein B-100 (apoB-100) of low density lipoprotein linked by a disulfide bond. Apo(a) and apoB-100 are synthesized by the liver and covalently associate or couple to form Lp(a) extracellularly. Elevated plasma Lp(a) is an independent risk factor for vascular injury disorders such as restenosis after balloon angioplasty and accelerated graft atherosclerosis following heart transplantation. Lp(a) is not expressed in laboratory animals making studies of its pathophysiology difficult. To overcome this problem, we explored the possibility of generating Lp(a) in rabbit plasma using replication-deficient adenovirus vector mediated gene delivery. Rabbits were chosen because of their large vessels and unlike mouse or rat, rabbit apoB-100 could interact with apo(a) to generate Lp(a). The recombinant (r) adenovirus vector construct used encoded a 200 kDa apo(a) [Ad-apo(a)]. Ad-apo(a) injection into the rabbit marginal vein caused the appearance of plasma rLp(a). Injection of a r adenovirus vector expressing the bacterial LacZ gene (Ad-LacZ) or PBS (vehicle) did not result in detectable plasma rLp(a). These are the first results to demonstrate plasma expression of rLp(a) in rabbits using adenovirus vector mediated gene transfer. Therefore, this system may be suitable for investigating Lp(a)'s role in the development of vascular injury diseases in a rabbit model. (C) 1999 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:322 / 328
页数:7
相关论文
共 50 条
  • [21] Adenovirus-mediated expression of green fluorescent protein
    R de Martin
    M Raidl
    E Hofer
    BR Binder
    Gene Therapy, 1997, 4 : 493 - 495
  • [22] Local adenovirus-mediated delivery of hirudin in a rabbit arterial injury model
    Bishop, GG
    Wiegman, P
    McNamara, C
    Din, S
    Sanders, J
    Hesselbacher, S
    Feldman, M
    McPherson, JA
    Humphries, JE
    Hammarskjold, ML
    Gimple, LW
    Ragosta, M
    Powers, ER
    Dickek, D
    Owens, GK
    Sarembock, IJ
    JOURNAL OF VASCULAR RESEARCH, 1999, 36 (05) : 343 - 352
  • [23] Recombinant adenovirus-mediated overexpression of 3β-hydroxysteroid-Δ24 reductase
    Lu, Xiuli
    Jia, Dan
    Zhao, Chenguang
    Wang, Weiqi
    Liu, Ting
    Chen, Shuchao
    Quan, Xiaoping
    Sun, Deliang
    Gao, Bing
    NEURAL REGENERATION RESEARCH, 2014, 9 (05) : 504 - 512
  • [24] Recombinant adenovirus-mediated overexpression of 3β-hydroxysteroid-Δ24 reductase
    Xiuli Lu
    Dan Jia
    Chenguang Zhao
    Weiqi Wang
    Ting Liu
    Shuchao Chen
    Xiaoping Quan
    Deliang Sun
    Bing Gao
    NeuralRegenerationResearch, 2014, 9 (05) : 504 - 512
  • [25] Development of an adenovirus vector lacking the expression of virus-associated RNAs
    Machitani, Mitsuhiro
    Katayama, Kazufumi
    Sakurai, Fuminori
    Matsui, Hayato
    Yamaguchi, Tomoko
    Suzuki, Takayuki
    Miyoshi, Hiroyuki
    Kawabata, Kenji
    Mizuguchi, Hiroyuki
    JOURNAL OF CONTROLLED RELEASE, 2011, 154 (03) : 285 - 289
  • [26] Lipoprotein(a) vascular accumulation in mice - In vivo analysis of the role of lysine binding sites using recombinant adenovirus
    Hughes, SD
    Lou, XJ
    Ighani, S
    Verstuyft, J
    Grainger, DJ
    Lawn, RM
    Rubin, EM
    JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (06) : 1493 - 1500
  • [27] Efficacy of recombinant adenovirus as vector for allergen gene therapy in a mouse model of type I allergy
    S Sudowe
    E Montermann
    J Steitz
    T Tüting
    J Knop
    A B Reske-Kunz
    Gene Therapy, 2002, 9 : 147 - 156
  • [28] Efficacy of recombinant adenovirus as vector for allergen gene therapy in a mouse model of type I allergy
    Sudowe, S
    Montermann, E
    Steitz, J
    Tüting, T
    Knop, J
    Reske-Kunz, AB
    GENE THERAPY, 2002, 9 (02) : 147 - 156
  • [29] THE INVERSE ASSOCIATION OF PLASMA LIPOPROTEIN(A) CONCENTRATIONS WITH APOLIPOPROTEIN(A) ISOFORM SIZE IS NOT DUE TO DIFFERENCES IN LP(A) CATABOLISM BUT TO DIFFERENCES IN PRODUCTION-RATE
    RADER, DJ
    CAIN, W
    IKEWAKI, K
    TALLEY, G
    ZECH, LA
    USHER, D
    BREWER, HB
    JOURNAL OF CLINICAL INVESTIGATION, 1994, 93 (06) : 2758 - 2763
  • [30] Development of Recombinant Adenovirus Carrying MicroRNA-regulated Gene Expression System
    Sakurai, Fuminori
    Mizuguchi, Hiroyuki
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2010, 130 (11): : 1497 - 1504